Generic Drug Makers Sue H. Lundbeck Over Cipramil Patent
Lundbeck's European patents for Cipramil expired at the beginning of 2002, allowing generic drug makers to start producing and selling cheaper generic versions. Lundbeck has been fending off generic drug makers by taking out patents for Cipramil's production methods and by filing lawsuits for patent infringement on those patents.
Following a number of legal...
To view the full article, register now.